Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Rating of “Hold” from Analysts

Hyperfine, Inc. (NASDAQ:HYPR) has received a consensus recommendation of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $1.7833.

Several analysts have weighed in on the stock. B. Riley Financial reaffirmed a “buy” rating on shares of Hyperfine in a research note on Wednesday, May 13th. Lake Street Capital increased their price target on shares of Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research note on Thursday, March 19th. BTIG Research began coverage on shares of Hyperfine in a research note on Wednesday, April 29th. They set a “buy” rating and a $2.00 price target on the stock. Zacks Research raised shares of Hyperfine to a “hold” rating in a research note on Thursday, March 19th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a research note on Tuesday, April 21st.

Insider Buying and Selling

In other Hyperfine news, CFO Brett Hale sold 24,188 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the transaction, the chief financial officer directly owned 275,812 shares of the company’s stock, valued at approximately $333,732.52. This trade represents a 8.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Thomas Teisseyre sold 24,188 shares of the firm’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the completion of the transaction, the chief operating officer directly owned 354,648 shares in the company, valued at approximately $429,124.08. The trade was a 6.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 60,470 shares of company stock worth $78,490. Insiders own 26.33% of the company’s stock.

Institutional Investors Weigh In On Hyperfine

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Walleye Capital LLC acquired a new stake in Hyperfine in the 4th quarter valued at $212,000. Bridgeway Capital Management LLC increased its stake in Hyperfine by 50.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company’s stock valued at $117,000 after buying an additional 40,000 shares during the last quarter. XTX Topco Ltd increased its stake in Hyperfine by 47.9% in the 4th quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock valued at $79,000 after buying an additional 26,165 shares during the last quarter. Cerity Partners LLC acquired a new stake in Hyperfine in the 4th quarter valued at $59,000. Finally, Millennium Management LLC acquired a new stake in Hyperfine in the 4th quarter valued at $55,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Trading Down 0.7%

Shares of HYPR opened at $1.49 on Thursday. Hyperfine has a 12-month low of $0.61 and a 12-month high of $2.22. The company has a quick ratio of 4.90, a current ratio of 5.52 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $147.91 million, a price-to-earnings ratio of -3.63 and a beta of 1.38. The stock’s 50-day moving average price is $1.38 and its 200 day moving average price is $1.20.

Hyperfine (NASDAQ:HYPR) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 98.83% and a negative net margin of 226.88%.The firm had revenue of $3.90 million for the quarter, compared to analyst estimates of $3.54 million. As a group, research analysts predict that Hyperfine will post -0.34 earnings per share for the current year.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.